Home › NDC Lookup › RxCUI directory › RxCUI 968851

Nicotine 4 MG Oral Lozenge [Nicorette] — RxCUI 968851

RxNorm drug concept · Semantic branded drug
RxCUI 968851 Semantic branded drug · SBD ● Current RxNorm concept 13 FDA products 29 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI968851
Official nameNicotine 4 MG Oral Lozenge [Nicorette]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNicorette 4 MG Oral Lozenge; Nicorette 4 MG (nicotine polacrilex 22.2 MG) Oral Lozenge
FDA products mapped13
Package NDCs mapped29
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nicotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It eases withdrawal symptoms, including cravings, while you quit smoking. You need to stop smoking completely when you start it. Finishing the full step-down program improves your...
  • Use dry, clean, hairless skin. Peel off the backing, press the patch on and hold it for 10 seconds. Change it at the same time each day, use a new spot, and wash your hands afterwa...
  • Vivid dreams and sleep trouble can happen. You can take the patch off at bedtime and put a new one on in the morning. If you crave cigarettes as soon as you wake up, wear it for th...
  • I'm having strange dreams or trouble sleeping. What should I do?
📖 Read our full Nicotine Transdermal Patch guide →

🕸️ Concept Web — How Nicotine 4 MG Oral Lozenge [Nicorette] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nicotine 4 MG Oral Lozenge [Nicorette] RxCUI 968851

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nicotine 7407
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nicorette 203808
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nicotine Oral Lozenge 379040
    • Nicotine Lozenge Product 1294869
    • Nicotine Oral Product 1158680
    • Nicotine Oral Lozenge [Nicorette] 968848
    • Nicorette Lozenge Product 1296535
    • Nicorette Oral Product 1183374
    • Oral Lozenge 316992
    • Lozenge Product 1294702
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nicotine 4 MG Oral Lozenge SCD · 359818
  • Nicotine 4 MG SCDC · 330548
  • Nicotine Oral Lozenge SCDF · 379040
  • Nicotine Lozenge Product SCDG · 1294869
  • Nicotine Oral Product SCDG · 1158680

Brand-Name Concepts

  • Nicotine 4 MG [Nicorette] SBDC · 968850
  • Nicotine Oral Lozenge [Nicorette] SBDF · 968848
  • Nicorette Lozenge Product SBDG · 1296535
  • Nicorette Oral Product SBDG · 1183374
  • Nicorette BN · 203808

📦 FDA Products & Package NDCs

13 products · 29 package NDCs
29 package NDCs map to RxCUI 968851 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00135-0508-02 3 CONTAINER in 1 CARTON (0135-0508-02) / 27 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2010-03-01
00135-0508-03 5 CONTAINER in 1 CARTON (0135-0508-03) / 27 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2010-03-01
00135-0508-04 20 LOZENGE in 1 CONTAINER (0135-0508-04) NICORETTE Haleon US Holdings LLC 2010-03-01
00135-0510-01 3 CONTAINER in 1 CARTON (0135-0510-01) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2010-10-19
00135-0510-06 1 CONTAINER in 1 CARTON (0135-0510-06) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2015-09-01
00135-0510-07 6 CONTAINER in 1 CARTON (0135-0510-07) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2015-09-01
00135-0511-01 3 CONTAINER in 1 CARTON (0135-0511-01) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2010-10-19
00135-0511-06 1 CONTAINER in 1 CARTON (0135-0511-06) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2015-09-01
00135-0511-07 6 CONTAINER in 1 CARTON (0135-0511-07) / 24 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2015-09-01
00135-0625-01 1 CONTAINER in 1 CARTON (0135-0625-01) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-04-11
00135-0625-02 4 CONTAINER in 1 CARTON (0135-0625-02) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-04-11
00135-0625-03 6 CONTAINER in 1 CARTON (0135-0625-03) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-10-23
00135-0626-01 1 CONTAINER in 1 CARTON (0135-0626-01) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-04-11
00135-0626-02 4 CONTAINER in 1 CARTON (0135-0626-02) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-04-11
00135-0626-03 6 CONTAINER in 1 CARTON (0135-0626-03) / 20 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2019-10-23
00135-0635-01 3 CONTAINER in 1 CARTON (0135-0635-01) / 72 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2022-06-01
00135-0636-01 3 CONTAINER in 1 CARTON (0135-0636-01) / 72 LOZENGE in 1 CO... NICORETTE Haleon US Holdings LLC 2022-06-01
00135-1500-01 20 LOZENGE in 1 CONTAINER (0135-1500-01) NICORETTE Haleon US Holdings LLC 2022-06-01
00135-1500-02 3 VIAL in 1 CARTON (0135-1500-02) / 27 LOZENGE in 1 VIAL NICORETTE Haleon US Holdings LLC 2022-06-01
00135-2800-01 20 LOZENGE in 1 CONTAINER (0135-2800-01) NICORETTE Haleon US Holdings LLC 2022-06-01
00135-2800-02 3 VIAL in 1 CARTON (0135-2800-02) / 27 LOZENGE in 1 VIAL NICORETTE Haleon US Holdings LLC 2022-06-01
00135-8050-20 1 VIAL in 1 PACKAGE (0135-8050-20) / 20 LOZENGE in 1 VIAL Nicorette Peppermint Haleon US Holdings LLC 2025-09-01
00135-8050-81 3 VIAL in 1 PACKAGE (0135-8050-81) / 27 LOZENGE in 1 VIAL Nicorette Peppermint Haleon US Holdings LLC 2025-09-01
00135-8060-20 1 VIAL in 1 PACKAGE (0135-8060-20) / 20 LOZENGE in 1 VIAL Nicorette Peppermint Haleon US Holdings LLC 2025-09-01
00135-8060-81 3 VIAL in 1 PACKAGE (0135-8060-81) / 27 LOZENGE in 1 VIAL Nicorette Peppermint Haleon US Holdings LLC 2025-09-01
00135-8070-20 1 VIAL in 1 PACKAGE (0135-8070-20) / 20 LOZENGE in 1 VIAL Nicorette Cherry Peppermint Haleon US Holdings LLC 2026-04-01
00135-8070-81 3 VIAL in 1 PACKAGE (0135-8070-81) / 27 LOZENGE in 1 VIAL Nicorette Cherry Peppermint Haleon US Holdings LLC 2026-04-01
00135-8071-20 1 VIAL in 1 PACKAGE (0135-8071-20) / 20 LOZENGE in 1 VIAL Nicorette Cherry Peppermint Haleon US Holdings LLC 2026-04-01
00135-8071-81 3 VIAL in 1 PACKAGE (0135-8071-81) / 27 LOZENGE in 1 VIAL Nicorette Cherry Peppermint Haleon US Holdings LLC 2026-04-01
Observed labelers: Haleon US Holdings LLC (29) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.